Biomarker Tests for Molecularly Targeted Therapies Key to Unlocking Precision Medicine (2016) / Chapter Skim
Currently Skimming:
Appendix A: Committee Member and Staff Biographies
Appendix A: Committee Member and Staff Biographies
Pages 227-240
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 227... ...
Army Breast Cancer Program, co-chair of the Breast Cancer Progress Review Group for the National Cancer Institute (NCI) , and chair of the NCI Cancer Centers review panel.
|
From page 228... ...
Liddle Award for Promoting an Interest in Research Among Physicians, the T.J. Martell Lifetime Scientific Achievement Award, and the AACR Lifetime Achievement in Cancer Research Award.
|
From page 229... ...
A founding faculty member of the internal medicine residency at San Francisco General Hospital–UCSF, she developed graduate medical education curricula focused on the care of the urban underserved. She serves on the Training Advisory Committee of the University of Zimbabwe Medical Education Partnership Initiative and is a member of the Scientific Advisory Board of Accordia Global Health Foundation and the Infectious Diseases Institute of Makerere University, Kampala.
|
From page 230... ...
As CSO, Dr. Frueh led all genomic operations, including nonclinical microbiome testing, high throughput, nextgeneration genomic sequencing, and research collaborations and partnerships, including the program with the University of California, San Diego/Moores Cancer Center.
|
From page 231... ...
Dr. Leonard is a leading expert in molecular pathology and genomic medicine, applying our understanding of the human genome and pathogen genomes to the diagnosis and treatment of human diseases, including inherited disorders, cancers, and infectious diseases.
|
From page 232... ...
He was most recently director of Comparative Effectiveness and Outcomes Research–Oncology at Duke University and the Duke Cancer Institute, where he also served as professor of medicine in the Duke University School of Medicine and a Senior Fellow at the Duke Center for Clinical Health Policy Research. In addition to his training in Internal Medicine at University of North Carolina at Chapel Hill and Hematology/Oncology at Roswell Park Cancer Institute, Dr.
|
From page 233... ...
He is an active grant reviewer for the National Cancer Institute, Conquer Cancer Foundation, American Association for Cancer Research, and Canadian Institute of Health Research.
|
From page 234... ...
joined Genentech in August 2015 as vice president and head of all BioOncology US Medical Affairs. Previously, she served as the deputy director at-large for the Mayo Clinic Cancer Center, group vice chair of the Alliance for Clinical Trials in Oncology, and chair of the Breast Cancer Specialty Council formed in 2012; she retains her academic appointment as a professor of medicine at Mayo Medical School and chair of the Mayo Clinic Breast Cancer Translational Genomics Program started in 2009.
|
From page 235... ...
Durling Professorship of Medicine; Honorary Doctorate of Letters, University of North Florida; Mayo Clinic Distinguished Investigator; Florida State Biomedical Research Advisory Council; Alpha Omega Alpha Honor Medical Society; Mayo Clinic Outstanding Course Director; EVE Award for Lifetime Achievement; NFL Hispanic Heritage Leadership Award; 1 of the 75 Most Influential People in Jacksonville Healthcare from Jacksonville Magazine's 904 (2012) ; The Girls Inc.
|
From page 236... ...
He currently serves on the external advisory board for a dozen national cancer centers, and directs the biostatistics and bioinformatics cores for the NCI-funded Vanderbilt University Breast Cancer SPORE, Gastrointestinal Cancer SPORE, and other program projects. In addition, Dr.
|
From page 237... ...
He collaborates with a wide range of domestic and international public and private health care organizations on issues of comparative effectiveness, health technology assessment, evidence-based medicine, clinical research, reimbursement, and medical technology policy. Through September 2005, Dr.
|
From page 238... ...
Jonathan Phillips is a research associate for the National Academies of Sciences, Engineering, and Medicine's Board on Health Care Services. Previously, he worked in clinical research at The University of Texas MD Anderson Cancer Center, providing clinical trial and translational research support for Principal Investigators in the Department of Gastrointestinal Medical Oncology and the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
|
From page 239... ...
With a Ph.D. in Cell and Tumor Biology from Georgetown University and postdoctoral training at the Johns Hopkins University School of Medicine, she has published papers on the cell and molecular biology of breast cancer.
|
From page 240... ...
In his capacity at the Academies, Dr. Berger has facilitated numerous policy discussions on innovative, new health care technologies and applications, helped establish collaborative projects among stakeholder groups, and planned and conducted many public workshops and written resulting reports, such as Stem Cell Therapies: Opportunities for Ensuring the Quality and Safety of Clinical Offerings; The Economics of Genomic Medicine; GenomeBased Diagnostics: Clarifying a Pathway to Clinical Use; Integrating LargeScale Genomic Information into Clinical Practice; Genome-Based Therapeutics: Targeted Drug Discovery and Development; Assessing Genomic Sequencing Information for Health Care Decision Making; and The Value of Genetic and Genomic Technologies.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.